ANTI-MICROBIAL EVALUATION OF NEW THIAZOLO PYRIMIDINE DERIVATIVES by Fayed, Ahmed A. & Ghanem, Samah
European Scientific Journal   November 2013  edition vol.9, No.33  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
 
184 
 
ANTI-MICROBIAL EVALUATION OF NEW 
THIAZOLO PYRIMIDINE DERIVATIVES 
 
 
 
Ahmed A. Fayed 
Respiratory Therapy Department (Applied organic and Biochemistry 
Division), College of Medical Rehabilitation Sciences, Taibah University, 
Almadinah Almunawarah, Saudi Arabia National Research Center, Cairo, 
Egypt 
Samah Ghanem 
Medical Laboratory Technology Department, College of Applied Medical 
Sciences, Taibah University, Almadinah Almunawarah, Saudi Arabia 
Helwan University, Cairo, Egypt 
 
 
Abstract 
Twelve new heterocyclic compounds containing thiazolo pyrimidine 
moiety were thus synthesized.. Compound 2 was synthesized by reaction of 
α-amino naphthol 1 with potassium isothiocyanate. Reaction of compound 2 
with sodium nitrite and hydrochloric acid afforded the corresponding 
diazonuim salt 3, which converted to 2-hydrazino thiazolo derivatives 4. 
Compound 2 carried out to synthesize imidazolo thiazolo derivative 5, 6 and  
thiazolo pyrimidino derivative 7, 8 and 9 respectively.  Compound 4 was 
carried out to synthesize of compound 10. Compound 10 was carried out to 
synthesize of triazolo thiazolo and thiadiazolo derivatives 11 and 12 
respectively. The structures of all newly synthesized compounds were 
elucidated by elemental analysis, IR, 1H-NMR and mass spectral data. The 
assignments of the new products were tested for Anti-microbial activities. 
Results are suggesting thiazolo pyrimidine derivatives emerge as valuable 
compounds with great potential to be used as antibacterial and antifungal 
agents, and as promising candidates for further efficiency evaluation. The 
detailed synthesis, spectroscopic data and Anti-microbial activities are 
reported. 
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Introduction 
The pyrimidine nucleus is present in a wide range of bioactive natural 
products. In addition, the pharmacological and biological activities of 
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pyrimidine derivatives are well documented (Grover et al., 1995; Haggarty et 
al., 2000; Kappe, 2000; Numazi et al., 2001; Kheder et al., 2008). Pyrimidine 
derivatives have been previously reported to be platelet aggregation 
inhibitors, antagonists, anti-coceptive and anti-parkinsonism (Nagawadeet 
al.,2005; Butnariu et al., 2009; Guan et al., 2010; Mojahidi et al., 2010). 
Also, hetero cyclic compounds exhibited anthelmintic, anti HIV activity and 
hypoglycemic activity (Rao et al., 2004). Pyrimidine derivatives were found 
to possess a variety of pronounced activities such as anti-microbial, analgesic 
(Fayed et al., 2009; Bahashwan, 2011), antimicrobial (Mosharef et al.,  2006; 
Rashad(i)  et al., 2010), anti-avian influenza virus (H5N1) ( Rashad (ii) et al., 
2010), against herpes simplex virus type-1 (HSV-1) and hepatitis-A virus 
(HAV), serotonin 5-HT6 receptor antagonist (Ramakrishna et al., 2011), 
Antiarrhythmic (Abdel-hafez et al., 2009). Thiazolopyrimidines have 
hypoglycemic, hypolipidemic, antidiabetic and antileshimanial activities 
(Lee et al., 2005). Pyrimidine derivatives have biological activities ranging 
from kinase inhibitors, treatment of disease states associated with 
angiogenesis [plated derived growth factor, PDGFr, fibroblast growth factor, 
FGFr, and epidermal growth factor, (EGFr) (Boschelli et al., 1998). The 
analogous mitogen-activated protein (CSBP/P38) kinase inhibitor, 
telomerase inhibitor, treatment of arthritis, adult respiratory distress 
syndrome, chronic obstructive pulmonary disease, or Alzheimer’s disease 
(Boehm et al., 2003). Arylazopyrimidine derivatives showed antitumor 
activity and anticancer activity (Buddh et al., 2011). In view of these 
observations and as continuation of our previous works in heterocyclic 
chemistry, we have herein synthesized some new thiazolopyrimidine, and 
tested their anti-microbial activities in comparison to Tetracycline and 
Ketoconazole were used as standard drugs.  
 
Materials and Methods 
Chemistry  
          Melting points were determined on open glass capillaries using an 
Electro thermal IA 9000 SERIES digital melting point apparatus (Electro 
thermal, Essex, U.K.) and are uncorrected. Elemental analyses were 
performed with all final compounds on Elementar, Vario EL, Micro 
analytical Unit, National Research Centre, Cairo Egypt and were found 
within ~ 0.4% of the theoretical values. Analytical data were obtained from 
the Micro analytical Unit, Cairo University, Egypt. The IR spectra (KBr) 
were recorded on a FT IR-8201 PC spectrophotometer .The 1H-NMR 
spectra was measured with Jeol FTGNM-EX 270, 270 MHz instrument in 
DMSO-d6 and the chemical shifts were recorded in (δ, ppm) relative to TMS. 
The Mass spectra were run at 70 eV with a Finnigan SSQ 7000 spectrometer 
using EI and the values of m/z are indicated in Dalton. TLC (Silica gel, 
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aluminum sheets 60F254, Merck, Darmstadt, Germany) followed the 
reactions.  
 
2-Amino naphthalino [1,2-d]thiazole (2) 
A mixture of compound 1 (0.01 mol) and KSCN (0.01 mol) in acetic 
acid (50 ml) was placed in freezing mixture and stirred mechanically with 
addition of Br2 (0.2mol) for 2hrs., at 0-100C.The reaction mixture was 
poured onto ice-water, the formed solid product was collected by filtration, 
washed with water, dried and crystallized from ethanol to give compound 2 
as green powder. Yield 68%; mp 285°C; IR (KBr, cm-1): 3285 (NH2); 1H-
NMR (DMSO-d6): δ: 6.14 (s, 2H, NH2, exchangeable with D2O),7.12-
7.38(m,6H,ArH)ppm; MS m/z (%) 200(M+,23) corresponding to the 
molecular formula C11H8N2S and at 184 (100, base peak). 
 
2-Diazo naphthalino [1,2-d]thiazole (3) 
A stirred solution of compound 2 (0.01 mol) in 35% HCL (10ml) was 
diazotized at 0-5 0C by a solution of 30% aqueous NaNO2. Then, the solution 
poured onto ice water and the solid product was crystallized from ethanol to 
give compound 3 as yellow powder. Yield 67%; mp 248 oC; IR (KBr, cm-1): 
1615-1430(C=N,C=C,Ar); 1H-NMR (DMSO-d6)δ: 6.92-7.41(m,6H,Ar-
H)ppm; MS m/z (%): 212(M+,38) corresponding to the molecular formula 
C11H6N3S and at 126(100, base peak). 
 
2-Hydrazino naphthalino [1,2-d]thiazole (4) 
A mixture of diazonium salt 3 (0.01 mol) and stannous chloride (0.01 
mol) in concentrated hydrochloric acid (40 ml) was stirred over night at 
room temperature. After cooling (-10oC), the obtained solid was filtered off, 
washed with water, dried, and crystallized from the ethanol to give 
compound 4 as brown powder. Yield 79%; mp 262oC; IR (KBr, cm-1): 3340-
3280 (NH, NH2); 1H-NMR (DMSO-d6) δ: 5.67 (s,1H,NH, exchangeable 
with D2O), 7.12-7.65 (m,6H,Ar-H), 10.31 (b, 2H,NH2, exchangeable with 
D2O) ppm; MS m/z (%): 215 (M+, 21) corresponding to the molecular 
formula C11H9N3S and at 132 (100, base peak).  
 
4-Oxo-3H-imidazolo[3,2-b]naphthalino [1,2-d] thiazole (5) 
A mixture of compound 2 (0.1 mol) and ethyl chloroacetate (0.1 mol)  
in poly phosphoric acid (30 ml) was refluxed for 3hrs. The reaction mixture 
was poured into water, neutralized with sodium carbonate the separated solid 
was collected and crystallized from ethanol to give compound 5 as reddish 
brown. Yield 71%; mp 300°C; IR (KBr, cm-1): 1685(C=O amid); 1H-NMR 
(DMSO-d6)δ: 6.15(s,2H,CH2), 6.89-7.34(m,6H,ArH)ppm; MS m/z (%): 240 
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(M+,19) corresponding to the molecular formula C13H8N2SO and at 158 
(100, base peak).  
 
4-(4-chloro phenyl) imidazolo[3,2-b]naphthalino [1,2-d] thiazole (6) 
A mixture of compound 2 (0.1 mol) and phenacyl bromide (0.1 mol)  
in glacial acetic acid (30 ml), in the presence of few drops tri ethylamine, 
was refluxed for 3h. The reaction mixture was poured into water, the 
separated solid was collected and crystallized from ethanol to give 
compound 6 as brown. Yield 59%; mp over300 °C; IR (KBr, cm-1):1620-
1435 (C=N,C=C,Ar); 1H-NMR 111(DMSO-d6)δ: 6.92-7.64 (m, 11H, 
ArH)ppm; MS m/z (%): 334 (M+,31) corresponding to the molecular formula 
C19H11N2SCl and at 183 (100, base peak). 
 
3,5-Dioxo-4H-pyrimidino [3,2-b]naphthalino [1,2-d] thiazole (7) 
A mixture of compound 2 (0.1 mol) and diethyl malonate  (0.1 mol)  
in glacial acetic acid (30 ml), in the presence of few drops tri ethyl amine, 
was refluxed for 3hrs. The reaction mixture was poured into water, the 
separated solid was collected and crystallized from ethanol to give 
compound 7 as green. Yield 64%; mp 297 °C; IR (KBr, cm-1): 1690(C=O 
amid); 1715(C=O amid); 1H-NMR (DMSO-d6)δ: 7.14-7.52(m,6H,ArH)ppm; 
MS m/z(%): 268(M+,31) corresponding to the molecular formula 
C14H8N2SO2 and at 172(100, base peak). 
 
Synthesis of  pyrimidino thiazole derivatives 8 and 9 
A solution of compound 2 (0.01mol) in DMF (20ml) was added 
benzylidine ethyl cyano acetate and benzylidine malononitrile respectively 
(0.01 mol) and piperidine (2drops) refluxed 3hrs. Then, the solvent was 
evaporated under reduced pressure and the remaining product was titurated 
with water and acidified with concentrated HCL. After filtration the 
separated solid was collected and crystallized from proper solvent to give 
compounds 8 and 9 respectively.  
 
3-Amino-4-ethoxy carbonyl – 5 - (4-chloro phenyl) pyrimidine [3,2 - b] 
naphthalino [1,2-d] thiazole (8) 
Yellow powder(62%),mp 225oC (EtOH/DMF). IR (KBr, cm-1): 3270 
(NH2), 1730(C=O ester); 1H-NMR (DMSO-d6) δ: 2.14 (t, 3H, CH3), 3.28 (q, 
2H, CH2), 6.84-7.25 (m, 6H, ArH), 7.54-7.87 (m, 5H, ArH), 10.31 (br, 2H, 
NH2 exchangeable with D2O) ppm;  MS m/z (%): 436 (M+, 42) 
corresponding to the molecular formula C23H18N3SO2CL and at 235 (100, 
base peak). 
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3-Amino-4-cyano – 5 - ( 4 - chloro phenyl) pyrimidine [3,2-b] 
naphthalino [1,2-d] thiazole (9) 
Brown powder (57%);mp over300oC (benzene). IR (KBr, cm-1): 3305 
(NH2), 2218(CN); 1H-NMR (DMSO-d6)δ: 7.15-7.36 (m, 6H, ArH), 7.41-
7.82(m, 5H, ArH), 10.43 (br, 2H, NH2 exchangeable with D2O) ppm;  MS 
m/z (%): 389 (M+,36) corresponding to the molecular formula C21H13N4SCL 
and at 198(100, base peak). 
 
N"[naphthalino [1,2-d] thiazol-2-yl]-N-(4-chloro phenyl) thio 
semicarbazide (10) 
A mixture of compound 4 (0.1 mol) and 4-chloro phenyl thiocyanate 
(0.1 mol) in glacial acetic acid (40 ml), was placed in freezing mixture and 
stirred mechanically for 3hrs. at 0-100C.The reaction mixture was poured 
onto ice-water, the formed solid product was collected by filtration, washed 
with water, dried and crystallized from ethanol to give compound 10  as 
yellow powder. Yield 76%; mp 246°C; IR (KBr, cm-1): 3197-
3262(3NH),1610-1438 (C=N, C=C, Ar); MS m/z (%) 350(M+,48) 
corresponding to the molecular formula C18H14N4S2 and at 184 (100, base 
peak). 
 
Synthesis of thiazolo derivatives 11 and 12 
A mixture of compound 10 (0.01mol) and phenacyl bromide and 
chloro acetic acid respectively (0.01 mol) in ethanol (30ml) was refluxed for 
3hrs. The reaction mixture was poured into water, the separated solid was 
collected and crystallized from proper solvent to give compounds 11 and 12 
respectively. 
 
2- [2-hydrazino -3, 4 - di (4 - chlorophenyl) - 4, 5 - dihydro thiazol-2-yl]  
naphthalino [1,2-d] thiazole (11) 
Yellow powder (59%);mp over300oC (EtOH). IR (KBr, cm-1): 3218 
(NH), 1617-1442 (C=N,C=C,Ar); 1H-NMR (DMSO-d6) δ: 6.32 (s,2H,CH2), 
6.81-7.37 (m,6H,ArH), 7.42-7.89 (m,9H,ArH), 11.14 (s,1H, NH, 
exchangeable with D2O) ppm;  MS m/z (%): 521 (M+,41) corresponding to 
the molecular formula C23H18N3SOCL and at 158 (100, base peak). 
 
2-[2-hydrazino-3-(4-chlorophenyl)-3H-4-oxo thiazol-2-yl] naphthalino 
[1,2-d] thiazole (12) 
Brown powder (64%); mp 210oC (MeOH). IR (KBr, cm-1): 3265 
(NH), 1695 (C=O amide); 1H-NMR (DMSO-d6) δ: 6.12 (s,2H,CH2), 6.79-
7.28(m,6H,ArH), 7.32-7.64 (m,4H,ArH), 10.43 (br,1H,NH, exchangeable 
with D2O)ppm;  MS m/z (%): 381(M+,39) corresponding to the molecular 
formula C19H13N4SOCL and at 216 (100, base peak).  
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Anti-Microbial Activity 
         The newly tested compounds were evaluated in vitro for their 
antimicrobial activities. The antimicrobial activities are carried out against 
three bacterial strains Staphylococcus  aureus, Staphylococcus  epidermidis, 
Escherichia coli and three fungal strains Aspergillus fumigates, Aspergillus 
niger and Alternaria alternata  employing the nutrient agar disc diffusion 
method (Arthington et al. 2000)  at 100 µg/ ml concentration. Dimethyl 
sulphoxide (DMSO) was used as blank and it exhibited no activity against 
any of the used organisms. The antimicrobial activity was determined by 
measuring of the inhibition zone (Table 1), after 16 -20 hrs. of incubation at 
37 0C for bacterial strains and 3-4 days at 37 0C for fungal strains. 
Tetracycline and Ketoconazole were used as standard drugs bacterial and 
fungal strains, respectively at 30 µg/ ml concentration. 
 
The Minimum Inhibitory Concentration (MIC) 
A current definition of the minimum inhibitory concentration MIC is 
"the lowest concentration which resulted in maintenance or reduction of 
inoculums viability". The determination of the MIC involves a semi-
quantitative test procedure which gives an approximation to the least 
concentration of antimicrobial agent needed to prevent microbial growth. 
The method displays tubes of growth broth containing a test level of 
preservatives, into which inoculums of microbes was added. The end result 
of the test was the minimum concentration of antimicrobial. The serial 
dilution technique (Mostahar et al. 2006) was applied for the determination 
of MIC of the tested compounds 1-6 against two species of bacterial strains ( 
S. aureus and E. coli) and two species of fungal strains (A. niger and A. 
alternata). Dilution series were set up with 6.25, 12.5, 25, 50 and 100 µg/ ml 
of nutrient broth medium to each tube , 100 µl of standardized suspension of 
the test microbes (107 cells/ ml)were added and incubated at 37 0C for 24 hrs. 
(Table 2). 
 
Cytotoxicity Bioassay 
Brine Shrimp lethality bioassay (Mayer et al. 1982 & Jaki et al. 1999) 
is recent development in the assay which indicates cytotoxicity as well as a 
wide range of pharmacological activities (e.g. antimicrobial, anticancer, 
antiviral, insecticidal, pesticidal, AIDS, etc). In this method, the eggs of the 
brine shrimp, Artemia salina leach, were hatched for 48 hrs., to mice shrimp, 
38 gm of sea salt was weighed , dissolved in one liter of distilled water, 
filtered off and was kept in a small tank. The eggs were then added to the 
divided tank. Constant oxygen supply was provided and temperature 370C 
was maintained for 48 hrs. to hatch and mice the shrimp called as nauplii 
(Larvae). The solutions of compounds 1-6 were prepared by dissolving 10 
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mg of each compound in 2 ml of DMSO. From this stock, a series of solution 
5, 10, 20, 40 and 80 µg/ml were transferred to fifteen vials (three for each 
dilutions were used for each test sample and LC50 is the mean of three 
values) and one vial was kept as control having 2 ml of DMSO. Then about 
10 brine shrimp nauplii were applied to each of all experimental vials and 
control vial. The number of the nauplii that died after 24 hrs. was counted. 
The resulting data were transformed to the probit analysis for the 
determination of LC50 values for the five tested compounds (Table 3). 
 
Results and Discussion 
Chemistry   
In previous work we have reported the synthesis of thiazolo 
derivatives used α-amino naphthol 1. The reaction of compound 1 with 
KSCN afforded 2-amino thiazolo derivatives 2.The reaction of compound 2 
with sodium nitrite and hydrochloric acid afforded the corresponding 
diazonuim salt 3, which converted to starting material 2-hydrazino thiazolo 
derivatives 4. (Scheme 1).  
NH2
KSCN
N
S
NH2
N
S
N2 Cl
1 2 3
NaNO2
HCl
SnCl2 / HCl
N
S
NHNH2
4  
Scheme 1: Synthetic route of compounds 2 - 4 
 
The reaction of hydrazino thiazolo derivatives 4 with ethyl chloro 
acetate and phenacyl bromide  respectively  in the presence of ethanol 
afforded the corresponding imidazolo thiazolo derivative 5 and 6 
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respectively. Also, hydrazino thiazolo derivatives 4 was reacted with diethyl 
malonate to afford thiazolo pyrimidino derivative 7. Reaction of hydrazino 
thiazolo derivatives 4 with benzelidine derivatives gave  thiazolo pyrimidino 
derivative 8 and 9. (Scheme 2).  
N
S
NH2
S
N
N
NH2
NC
Ar
9
Ar
CN
CN
S
N
NO
5 CH
2 COOEt
Cl
S
N
NAr
6
Ar
C
O
CH 2
Br
S
N
N
O
O
7
CH2(COOEt)2
S
N
N
NH2EtOOC
Ar
8
Ar
CN
COOEt
2
Scheme 2
Ar =
Cl
 
Scheme2: Synthetic route of compounds 5 - 9 
 
Additionally, the compound 4 was reacted with p. chloro phenyl 
isothiocyanate afforded compound 10. Compound 10 reacted with p.chloro 
phenacyl bromide and chloro acetic acid respectively to afford thiazolo and 
thiadiazolo derivatives 11 and 12 respectively (Scheme 3).  
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Scheme 3: Synthetic route of compounds 10 - 12 
 
Anti-Microbial Activity 
The tested compounds 4, 5, 6, 7, 8, 9, 11 and 12 were evaluated in 
vitro for their anti-microbial activity. The antimicrobial activities are carried 
out against three bacterial strains, (Staphylococcus aureus, Staphylococcus 
epidermidis and Escherichia coli), and three fungal strains (Aspergillus 
fumigates, Aspergillus niger and Alternaria alternata). The preliminary 
screening results indicated that the most compounds showed antimicrobial 
activity from weak, moderate to good. From the inhibition zone diameter 
data analysis, compounds 4, 8 and 9 showed good inhibitions against all the 
species of bacterial but compounds 8 and 9 moderate inhibitions against A. 
niger and A. alternate. Compounds 5, 6 and 7 showed in general weak 
inhibitions against all the species of bacterial and fungal strains. Compounds 
11 and 12 showed in general moderate inhibitions against all the species of 
bacterial and fungal strains, but compound 12 showed good inhibition 
against A. alternata (Table 1). Many studies reported antimicrobial activities 
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of thiazolo pyrimidine derivatives (Habib et al, 2007; Rashad et al, 2010; 
Kotaiah et al, 2012). 
Table 1: The Antimicrobial activity of tested compounds at 100 µg/ml concentrations 
Compd. 
NO. 
Diameter of the inhibition zone a (mm) 
Bacteria Fungi 
S. aureus S. 
epidermidis 
E. 
Coli 
A.Fumigat
es 
A. niger A. Alternata 
4 27 25 24 21 20 22 
5 15 10 7 9 11 8 
6 10 9 5 12 9 10 
7 12 9 10 13 12 15 
8 23 22 26 20 18 17 
9 25 23 20 21 19 19 
11 16 18 16 15 17 18 
12 18 19 19 17 17 20 
Tertacycline
b 
29 26 28 - - - 
Ketoconazol
eb 
- - - 20 19 23 
a15mm or less weak inhibition, 16-20mm: moderate inhibition, 20mm or more: good  inhibition 
bThe concentration of used standard drugs was 30 µg/mL 
 
The Minimum Inhibitory Concentration (MIC) 
The minimum inhibitory concentration (MIC, µg/ ml) of the most 
active compounds 4,8 and 9  against two species of bacteria (S. epidermidis 
and E. coli) and also two species of fungi (A. niger and A. alternata) were 
determined (Table 2). Compounds 4, 8 and 9 demonstrated good inhibitions 
against the selected bacterial and fungal strains. 
Table2: The minimum inhibitory concentration (MIC, µg/ml) of tested compounds 4, 8 and 9 
The selected organisms The minimum inhibitory concentration 
(MIC) 
4 8 9 Standarda 
S. aureus 0.48 0.53 0.64 0.45 
E. coli 0.34 0.60 0.53 0.37 
A. niger 0.19 0.16 0.12 0.25 
A. alternata 0.46 0.39 0.41 0.30 
aTetracycline and Ketoconazole were used as standard drugs against bacterial and fungal strains, 
respectively. 
 
Cytotoxicity Activity                           
       The LC50 values of tested compounds 4,8 and 9  were found to be 
3.23, 5.14 and 2.22µg/ ml, respectively (Table 3). The standard drug 
Bleomycin has LC50 value at 0.41 g/ml. The lowest LC50 value was found in 
the case of compound 8 indicating higher cytotoxicity than the other 
compounds. Compounds 4 and 9 showed potent biocidal activity against 
brine shrimp due to their lower cytotoxicity that agreement with preliminary 
anti-microbial screening and the minimum inhibitory concentration (MIC). 
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Table3: Cytotoxicity activity of tested compounds 4, 8 and 9 
Comp. 
No 
95% confidence limit ppm Regression 
Equation 
X2(df) 
LC50 Lower Upper 
4 3.23 2.08 6.02 Y=3.98 + 1.85 X 3.38 (2) 
8 5.14 4.15 10.15 Y=3.17 + 2.27 X 0.35 (2) 
9 2.22 1.30 4.10 Y=4.36 + 1.78 X 0.32 (2) 
Bleomycina 0.41 0.27 0.62 Y=3.16 + 1.98 X 0.62 (2) 
Gallic Acida 4.56 3.35 6.12 Y=3.93 + 1.62 X 1.25 (2) 
aBleomycin and gallic acid were used as standard drugs in cytotoxicity activity. 
 
Structure Activity Relationship 
Structure activity relationships based on the obtained results indicated 
that, substitution of pyrimidine derivatives have anti-microbial activity. 
Compounds 4, 8 and 9 have high anti-microbial activity due to presence of 
electron-donating moiety which increase the pharmacological activity. This 
makes the sequence of ruling anti-microbial properties regarding substitution 
of electron –donating group in pyrimidine derivatives as, hydrazine ˃ amino 
ethoxy carbonyl ˃ amino cyano as exhibited in compounds 4 ˃ 8 ˃ 9 
respectively. Compounds 11 and 12 have moderate anti-microbial activity 
due to presence of hydrazino thiazole attached with electron-withdrawing 
moiety which decrease the pharmacological activity. This makes the 
sequence of ruling anti-microbial properties regarding substitution of 
electron-withdrawing group in pyrimidine derivatives as, carbonyl adjacent 
to phenyl ˃ diphenyl as exhibited in compounds 12 ˃ 11 respectively. Also, 
compounds 5, 6 and 7 have week anti-microbial activity due to presence of 
electron-withdrawing moiety which decrease the pharmacological activity. 
This makes the sequence of ruling anti-microbial properties regarding 
substitution of electron-withdrawing group in pyrimidine derivatives as, 
carbonyl of imidazole ˃ dicarbonyl of pyrimidine ˃ phenyl of imidazole as 
exhibited in compounds 5 ˃ 7 ˃ 6 respectively. 
 
Conclusion 
The objective of the present study was to synthesize and investigate 
the anti-microbial activity of new thiazolo pyrimidine derivatives. The 
starting material 2 was synthesized and carried out to synthesize thiazolo 
derivatives 4. Compound 2 carried out to synthesize imidazolo thiazolo 
derivative 5, 6 and  thiazolo pyrimidino derivative 7, 8 and 9 respectively.  
Compound 4 was carried out to synthesize of compound 10. Compound 10 
was carried out to synthesize of triazolo thiazolo and thiadiazolo derivatives 
11 and 12 respectively. The newly tested synthesized compounds 4, 5, 6, 7, 
8, 9, 11, 12 and the standard drug Tetracycline and Ketoconazole were found 
to exhibit essentially equipotent anti-microbial activity.  
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Results are suggesting thiazolo pyrimidine derivatives emerge as 
valuable compounds with great potential to be used as antibacterial and 
antifungal agents, and as promising candidates for further efficiency 
evaluation. 
Studying of biodegradability property of the produced thiazolo 
pyrimidine derivatives would be of great value for protecting and preserving 
the environment.  
Many studies reported successful biological degradation of many 
synthesized compounds (Daniel et al, 1999; El-Arnaouty et al, 2008; Shah et 
al, 2008; Abd El-Mohdy and Ghanem, 2009). 
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